Find More Contacts for Kypha
Protected Content
Chief Medical Officer, Health Professional, Medical Officer
Non-Management, Executive
1 email found 1 phone number found
View contacts for Kypha to access new leads and connect with decision-makers.
View All Contacts
  • Company Type For Profit
  • Contact Email info@kypha.net
  • Phone Number 314-282-2008

Kypha is an early-stage life sciences company developing leading-edge technology and clinically useful products to improve the way autoimmune and inflammatory disorders are monitored and treated. With a core team of nine, plus an extensive network of scientific advisors, clinical collaborators and business mentors, Kypha has leveraged Federal

grants and raised more than $3 million in private capital since 2011 to advance its lead diagnostic product – Comp Act Dx – toward FDA clearance and commercial launch in early 2014. Comp Act Dx is a simple yet revolutionary test that quickly measures the level of inflammation in the body – such as that caused by traumatic injury or autoimmune disease – with an unprecedented combination of speed and accuracy. Comp Act Dx is designed to allow superior monitoring of at-risk patients by measuring changes in inflammation in near-real time, thereby aiding medical professionals in making earlier, more effective clinical intervention decisions.

Lists Featuring This Company

Midwestern US Companies With More Than $1M in Revenue (Top 10K)
9,719 Number of Organizations • $407.5B Total Funding Amount • 15,020 Number of Investors
Medical Device Companies (Top 10K)
9,993 Number of Organizations • $205.9B Total Funding Amount • 20,077 Number of Investors
Health Care Companies With Less Than $10M in Revenue (Top 10K)
9,916 Number of Organizations • $285B Total Funding Amount • 44,609 Number of Investors
Health Care Companies With Less Than $500M in Revenue (Top 10K)
9,987 Number of Organizations • $663.4B Total Funding Amount • 55,763 Number of Investors

Frequently Asked Questions

Where is Kypha's headquarters? Kypha is located in Saint Louis, Missouri, United States.Who invested in Kypha? Kypha has 7 investors including Arsenal Capital Management and BioGenerator.How much funding has Kypha raised to date? Kypha has raised .When was the last funding round for Kypha? Kypha closed its last funding round on May 12, 2022 from a Venture - Series Unknown round.Who are Kypha's competitors? Alternatives and possible competitors to Kypha may include Tandem Diabetes CareSesen Bio, and Injectsense.